Have a feature idea you'd love to see implemented?
Let us know!
AXGN Axogen Inc
Price (delayed)
$13.73
Market cap
$601.78M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.38
Enterprise value
$648.08M
Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore
Highlights
The company's EPS rose by 32% YoY and by 24% QoQ
Axogen's net income has increased by 30% YoY and by 22% QoQ
Axogen's quick ratio has decreased by 15% YoY but it has increased by 7% from the previous quarter
Axogen's gross margin has decreased by 3.2% YoY
Key stats
What are the main financial stats of AXGN
Market
Valuations
Earnings
Shares outstanding
43.83M
Market cap
$601.78M
Enterprise value
$648.08M
Price to earnings (P/E)
N/A
Price to book (P/B)
6.27
Price to sales (P/S)
3.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.74
Revenue
$173.48M
EBIT
-$9.36M
EBITDA
-$2.14M
Free cash flow
-$13.67M
Per share
Balance sheet
Liquidity
EPS
-$0.38
Free cash flow per share
-$0.31
Book value per share
$2.19
Revenue per share
$3.97
TBVPS
$4.21
Total assets
$188.93M
Total liabilities
$93.25M
Debt
$71.49M
Equity
$95.69M
Working capital
$58.85M
Debt to equity
0.75
Current ratio
3.51
Quick ratio
2.23
Net debt/EBITDA
-21.64
Margins
Efficiency
Dividend
EBITDA margin
-1.2%
Gross margin
77.8%
Net margin
-9.5%
Operating margin
-7%
Return on assets
-8.6%
Return on equity
-17.3%
Return on invested capital
-4.6%
Return on capital employed
-5.7%
Return on sales
-5.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AXGN stock price
How has the Axogen stock price performed over time
Intraday
0.88%
1 week
-2.9%
1 month
5.45%
1 year
213.47%
YTD
101.02%
QTD
-2.07%
Financial performance
How have Axogen's revenue and profit performed over time
Revenue
$173.48M
Gross profit
$134.96M
Operating income
-$12.21M
Net income
-$16.54M
Gross margin
77.8%
Net margin
-9.5%
AXGN's operating margin has soared by 58% YoY and by 39% QoQ
Axogen's operating income has soared by 51% YoY and by 35% from the previous quarter
The company's net margin rose by 40% YoY and by 27% QoQ
Axogen's net income has increased by 30% YoY and by 22% QoQ
Growth
What is Axogen's growth rate over time
Valuation
What is Axogen stock price valuation
P/E
N/A
P/B
6.27
P/S
3.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.74
The company's EPS rose by 32% YoY and by 24% QoQ
AXGN's P/B is 102% above its last 4 quarters average of 3.1 and 46% above its 5-year quarterly average of 4.3
The equity has increased by 2.7% QoQ
AXGN's P/S is 92% above its last 4 quarters average of 1.8 but 9% below its 5-year quarterly average of 3.8
The revenue has grown by 17% YoY and by 6% from the previous quarter
Efficiency
How efficient is Axogen business performance
The company's return on sales has surged by 66% YoY and by 45% QoQ
Axogen's return on invested capital has surged by 57% YoY and by 43% QoQ
The ROA has increased by 30% YoY and by 23% from the previous quarter
Axogen's ROE has increased by 27% YoY and by 22% from the previous quarter
Dividends
What is AXGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AXGN.
Financial health
How did Axogen financials performed over time
The total assets is 103% higher than the total liabilities
Axogen's quick ratio has decreased by 15% YoY but it has increased by 7% from the previous quarter
AXGN's current ratio is down by 2.5% year-on-year but it is up by 2.3% since the previous quarter
The company's debt is 25% lower than its equity
The equity has increased by 2.7% QoQ
The debt to equity has contracted by 2.6% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.